Legal & General Group PLC Cidara Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$1.87 - $2.7 $7,379 - $10,654
-3,946 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$2.85 - $4.1 $3,639 - $5,235
-1,277 Reduced 24.45%
3,946 $11,000
Q2 2020

Aug 14, 2020
BUY
$2.39 - $4.0 $12,482 - $20,892
5,223 New
5,223 $19,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email